Signal Note: FORTE (VNTXF)

BVF Partners' substantial 80% position increase—adding $12.8M despite existing $13.5M stake—signals high conviction alongside convergence from two other specialist biotech funds (OrbiMed, Perceptive). This three-fund overlap suggests emerging consensus on valuation or near-term catalyst visibility.

Unlock full AI analysis — 14-day free trial

7 quarters

Position Trend

Aug 6, 2025

0 funds

Aug 14, 2025

$24.0M

3 funds

Nov 14, 2025

$18.9M

2 funds

Feb 17, 2026

$32.6M

1 fund

+689% total institutional value over 14 quarters

Catalysts

No catalysts tracked.

Be first to know when this name moves

Fund buys and exits, insider activity, and catalyst alerts across 800+ biotechs — free Monday brief.

Activist Filings

SC 13G/APerceptive Advisors2.5%Feb 14, 2025

SC 13GOrbiMed Advisors8.0%Feb 14, 2025

SC 13G/APerceptive Advisors10.0%Nov 14, 2024

SC 13G/APerceptive Advisors9.9%Feb 14, 2024

SC 13GPerceptive Advisors9.9%Sep 8, 2023

SC 13G/AOrbiMed Advisors0.0%Feb 11, 2022

SC 13GOrbiMed Advisors4.7%Feb 12, 2021

Position Details

BVF PartnersEXITFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

24 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

EXAS1 fund CTMX1 fund IRON1 fund CRVS1 fund QTTB1 fund RLMD1 fund ADCT1 fund ACET1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer